🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Toulouse
NCT02877706 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * adult patients (18+ year-old) * newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB Exclusion criteria: \- opposition to data collection
💊

What it tests

  • no specific intervention
📍

Where

1 site
Service de Médecine Interne
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy